AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. SNY
  4. [6-K] Sanofi American Current Report (Foreign Issuer)

[6-K] Sanofi American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source:

Stock SNY logo
Sanofi FR

NASDAQ:SNY

SNY Rankings

#120 Ranked by Market Cap
#819 Ranked by Dividends

SNY Latest News

Aug 26, 2025
New Report Highlights Community Health Workers' Impact, Calls for Sustained Local Investment, During National CHW Awareness Week
Jul 22, 2025
BEYFORTUS® reduced hospital and doctor visits for RSV disease in babies by 87%, according to largest US real-world study
Jun 26, 2025
Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts
Jun 2, 2025
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
May 22, 2025
Sanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presence

SNY Latest SEC Filings

Aug 13, 2025
[SCHEDULE 13G/A] Sanofi American SEC Filing
Aug 7, 2025
[6-K] Sanofi American Current Report (Foreign Issuer)
Jul 31, 2025
[6-K] Sanofi American Current Report (Foreign Issuer)
Jul 31, 2025
[6-K] Sanofi American Current Report (Foreign Issuer)
Jul 31, 2025
[6-K] Sanofi American Current Report (Foreign Issuer)

SNY Stock Data

122.26B
2.53B
0%
10.36%
0.13%
Drug Manufacturers - General
Healthcare
France
Paris